UAMS Principal Investigator: Whit Hall, M.D., professor, neonatologist, UAMS College of Medicine, Department of Pediatrics
Summary: A phase 3 multi-site clinical trial comparing a symptoms-based drug treatment approach for neonatal opioid withdrawal syndrome (NOWS) with a scheduled tapering treatment.
Significance: Called OPTimize NOW, the study should determine the optimal treatment approach for newborns.
TRI Services: Regulatory and research coordinator services
Sponsor: HELP for NOWS Consortium